Skip to main content
. 2016 Aug 22;60(9):5546–5553. doi: 10.1128/AAC.00925-16

FIG 2.

FIG 2

Time to appropriate therapy in survivors and nonsurvivors, classified by MRSA/VISA categorization. MRVISA, methicillin-resistant vancomycin-intermediate Staphylococcus aureus; VISA, vancomycin-intermediate Staphylococcus aureus.